Francis GS - Search Results

1

Multiple sclerosis in French Canadians: evidence for HLA class II susceptibility and resistance genes.

Haegert DG, Michaud M, Francis GS. Haegert DG, et al. Among authors: francis gs. Can J Neurol Sci. 1990 Nov;17(4):382-6. doi: 10.1017/s0317167100030924. Can J Neurol Sci. 1990. PMID: 2125855

2

Contribution of a single DQ beta chain residue to multiple sclerosis in French Canadians.

Haegert DG, Francis GS. Haegert DG, et al. Among authors: francis gs. Hum Immunol. 1992 Jun;34(2):85-90. doi: 10.1016/0198-8859(92)90033-j. Hum Immunol. 1992. PMID: 1429036

3

No association between susceptibility to multiple sclerosis and HLA-DPB1 alleles in the French Canadian population.

Howell WM, Sage DA, Evans PR, Smith JL, Francis GS, Haegert DG. Howell WM, et al. Among authors: francis gs. Tissue Antigens. 1991 Apr;37(4):156-60. doi: 10.1111/j.1399-0039.1991.tb01864.x. Tissue Antigens. 1991. PMID: 1926123

4

Multiple sclerosis and HLA class II susceptibility and resistance genes.

Haegert DG, Michaud M, Schwab C, Francis GS. Haegert DG, et al. Among authors: francis gs. J Neurosci Res. 1990 May;26(1):66-73. doi: 10.1002/jnr.490260108. J Neurosci Res. 1990. PMID: 1972763

5

HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups.

Haegert DG, Francis GS. Haegert DG, et al. Among authors: francis gs. Neurology. 1993 Jun;43(6):1207-10. doi: 10.1212/wnl.43.6.1207. Neurology. 1993. PMID: 7909591

6

HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups.

Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG. Haegert DG, et al. Among authors: francis gs. Neurology. 1993 Mar;43(3 Pt 1):548-52. doi: 10.1212/wnl.43.3_part_1.548. Neurology. 1993. PMID: 8450999

7

Treatment of spasticity with tizanidine in multiple sclerosis.

Lapierre Y, Bouchard S, Tansey C, Gendron D, Barkas WJ, Francis GS. Lapierre Y, et al. Among authors: francis gs. Can J Neurol Sci. 1987 Aug;14(3 Suppl):513-7. doi: 10.1017/s0317167100038026. Can J Neurol Sci. 1987. PMID: 3676923 Clinical Trial.

8

Neuroimaging in multiple sclerosis.

Francis GS, Evans AC, Arnold DL. Francis GS, et al. Neurol Clin. 1995 Feb;13(1):147-71. Neurol Clin. 1995. PMID: 7739501 Review.

9

Treatment with interferon beta-1b improves quality of life in multiple sclerosis.

Rice GP, Oger J, Duquette P, Francis GS, Bélanger M, Laplante S, Grenier JF. Rice GP, et al. Among authors: francis gs. Can J Neurol Sci. 1999 Nov;26(4):276-82. doi: 10.1017/s031716710000038x. Can J Neurol Sci. 1999. PMID: 10563212 Clinical Trial.

10

Activated suppressor cell function in severely disabled patients with multiple sclerosis.

Antel JP, Freedman MS, Brodovsky S, Francis GS, Duquette P. Antel JP, et al. Among authors: francis gs. Ann Neurol. 1989 Feb;25(2):204-7. doi: 10.1002/ana.410250219. Ann Neurol. 1989. PMID: 2521994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters